There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

The authors used a light-transmission-based static division system to detect particles of foreign contaminants in prefilled vials.

Challenges and Strategies for Implementing Automated Visual Inspection for Biopharmaceuticals

Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business development, more...

Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President; More...

Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne Jones senior VP and chief information officer; more...

Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory Affairs; More...

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs, which the group is particularly concerned about.

EFCG: Counterfeit Medicines More Profitable than Heroin

Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San Francisco appoints VP of process science; more...

Week of Oct. 12, 2009: GSK and Prosensa Form Pact; Cardiokine Appoints CEO; More...

Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech; Sigma-Aldrich appoints VP and board member; more...

Week of Oct. 5, 2009: Merck and CSL Sign Flu Vaccine Pact; Cardinal Health Names VP; More...

AAPS President offers hope and solutions for the industry's challenging future.

Looking Ahead: The Pharmaceutical-Science Industry

Is the square root of (N) + 1 a statistically valid scheme?

Statistical Solutions: Square Root of (N) + 1 Sampling Plan

Industry, equipment vendors, and regulators are busy refining the precision and reliability of dissolution testing.

Getting the Truth out of Dissolution Testing

Wayne Jalenak is a senior application scientist at Ahura Scientific.

Robert Brush is an application scientist at Ahura Scientific.

Robert L. Green is a research scientist at Ahura Scientific, Inc., 46 Jonspin Road, Wilmington, MA 01887, tel. 978.657.5555, fax 978.657.5921, bgreen@ ahurascientific.com.

Christopher D. Brown is a director of system analytics and applications, both at Ahura Scientific, Inc.

Using handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used as raw materials.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes